Inova Lands $50M Gift for Personalized Oncology Research
News May 27, 2015
Inova recently announced a $50 million gift from Dwight Schar to launch a new oncology research institute at the Inova Center for Personalized Health in Fairfax, Virginia.
Donald "Skip" Trump will lead the cancer institute as CEO and executive director, Inova said.
The Inova Center for Personalized Health is part of the Inova Health System, a non-profit healthcare provider in Northern Virginia and the Washington, DC metro area. The Inova Translational Medicine Institute is also a part of the Inova system.
In a separate statement, the Fairfax County Economic Development Authority said that the new institute has as its goal, the creation of a leading center for translational cancer research and patient care based on genomics and individualized therapy. Researchers at the institute will develop new genomics-based tests, therapies, and population health processes. The institute will also collaborate with life science firms, resulting in the expansion of the life science economy in the Virginia and Washington region.
In April 2014, Inova announced it planned to offer whole-genome sequencing by prescription for sick newborns.
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE
Targeting the Engine Room of the Cancer CellNews
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018